Financhill
Sell
28

MPC Quote, Financials, Valuation and Earnings

Last price:
$133.29
Seasonality move :
8.83%
Day range:
$130.54 - $133.42
52-week range:
$130.54 - $221.11
Dividend yield:
2.54%
P/E ratio:
10.57x
P/S ratio:
0.33x
P/B ratio:
2.26x
Volume:
11M
Avg. volume:
2.7M
1-year change:
-13.18%
Market cap:
$42.9B
Revenue:
$148.4B
EPS (TTM):
$12.62
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $111.1B $69.8B $120B $177.5B $148.4B
Revenue Growth (YoY) 29.11% -37.22% 71.95% 47.9% -16.38%
 
Cost of Revenues $102.5B $69.1B $113.4B $154.9B $131.9B
Gross Profit $8.7B $671M $6.6B $22.6B $16.5B
Gross Profit Margin 7.82% 0.96% 5.51% 12.72% 11.12%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.2B $2.7B $2.5B $2.8B $3B
Other Inc / (Exp) -$480M -$9.5B $814M $2.5B $1.9B
Operating Expenses $3.8B $3.4B $3.3B $3.6B $3.8B
Operating Income $4.9B -$2.7B $3.4B $19B $12.7B
 
Net Interest Expenses $1.2B $1.4B $1.4B $998M $605M
EBT. Incl. Unusual Items $3.2B -$13.6B $2.8B $20.5B $14B
Earnings of Discontinued Ops. $806M $1.2B $8.4B $72M --
Income Tax Expense $784M -$2.4B $264M $4.5B $2.8B
Net Income to Company $3.3B -$10B $11B $16.1B $11.2B
 
Minority Interest in Earnings -$618M $151M -$1.3B -$1.5B -$1.5B
Net Income to Common Excl Extra Items $2.6B -$9.8B $9.7B $14.5B $9.7B
 
Basic EPS (Cont. Ops) $4.00 -$15.13 $15.34 $28.31 $23.73
Diluted EPS (Cont. Ops) $3.97 -$15.13 $15.24 $28.12 $23.63
Weighted Average Basic Share $659M $649M $634M $512M $407M
Weighted Average Diluted Share $664M $649M $638M $516M $409M
 
EBITDA $7.7B -$8.9B $7.4B $24.9B $18.6B
EBIT $4.5B -$12.3B $4.1B $21.7B $15.3B
 
Revenue (Reported) $111.1B $69.8B $120B $177.5B $148.4B
Operating Income (Reported) $4.9B -$2.7B $3.4B $19B $12.7B
Operating Income (Adjusted) $4.5B -$12.3B $4.1B $21.7B $15.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $17.4B $32.3B $45.8B $40.9B $35.1B
Revenue Growth (YoY) -36.82% 85.67% 41.66% -10.64% -14.2%
 
Cost of Revenues $17B $30.4B $39.6B $35.8B $33B
Gross Profit $435M $1.9B $6.2B $5.1B $2.1B
Gross Profit Margin 2.5% 5.95% 13.48% 12.57% 6.03%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $673M $681M $705M $804M $807M
Other Inc / (Exp) -$641M $292M $1.4B $666M $266M
Operating Expenses $851M $874M $929M $1B $1B
Operating Income -$416M $1B $5.2B $4.1B $1.1B
 
Net Interest Expenses $359M $328M $245M $138M $229M
EBT. Incl. Unusual Items -$1.4B $1B $6.4B $4.6B $1.1B
Earnings of Discontinued Ops. $371M -- -- -- --
Income Tax Expense -$436M -$18M $1.4B $1B $113M
Net Income to Company -$609M $1B $5B $3.6B $1B
 
Minority Interest in Earnings -$277M -$336M -$543M -$351M -$393M
Net Income to Common Excl Extra Items -$886M $694M $4.5B $3.3B $622M
 
Basic EPS (Cont. Ops) -$1.36 $1.10 $9.12 $8.31 $1.88
Diluted EPS (Cont. Ops) -$1.36 $1.09 $9.06 $8.28 $1.87
Weighted Average Basic Share $650M $633M $491M $394M $331M
Weighted Average Diluted Share $650M $637M $494M $396M $332M
 
EBITDA -$242M $2.2B $7.5B $5.8B $2.3B
EBIT -$1.1B $1.3B $6.7B $5B $1.5B
 
Revenue (Reported) $17.4B $32.3B $45.8B $40.9B $35.1B
Operating Income (Reported) -$416M $1B $5.2B $4.1B $1.1B
Operating Income (Adjusted) -$1.1B $1.3B $6.7B $5B $1.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $79.8B $102.6B $173B $151.9B $142B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $77.7B $97.3B $153.5B $132.8B $131.6B
Gross Profit $2.1B $5.4B $19.5B $19.1B $10.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.9B $2.5B $2.6B $2.9B $3.2B
Other Inc / (Exp) -$10.6B $734M $2.4B $1.6B $1.8B
Operating Expenses $3.6B $3.2B $3.4B $3.8B $4.1B
Operating Income -$1.4B $2.2B $16B $15.3B $6.3B
 
Net Interest Expenses $1.3B $1.4B $1.1B $663M $756M
EBT. Incl. Unusual Items -$13.4B $1.5B $17.3B $16.3B $7.3B
Earnings of Discontinued Ops. $1.1B $8.8B -- -- --
Income Tax Expense -$2.1B -$172M $3.8B $3.4B $1.2B
Net Income to Company -$10.3B $10.5B $13.5B $12.9B $6.2B
 
Minority Interest in Earnings $621M -$1.2B -$1.5B -$1.4B -$1.6B
Net Income to Common Excl Extra Items -$9.7B $9.2B $12B $11.6B $4.5B
 
Basic EPS (Cont. Ops) -$14.92 $14.11 $22.93 $26.91 $12.67
Diluted EPS (Cont. Ops) -$14.92 $14.01 $22.77 $26.78 $12.62
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$8.7B $6.2B $21.7B $20.8B $12B
EBIT -$12.1B $2.8B $18.5B $17.5B $8.7B
 
Revenue (Reported) $79.8B $102.6B $173B $151.9B $142B
Operating Income (Reported) -$1.4B $2.2B $16B $15.3B $6.3B
Operating Income (Adjusted) -$12.1B $2.8B $18.5B $17.5B $8.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $51.8B $84.6B $137.6B $112.1B $105.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $52.2B $80.4B $120.5B $98.5B $98.2B
Gross Profit -$421M $4.3B $17.1B $13.7B $7.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.1B $1.9B $2B $2.2B $2.4B
Other Inc / (Exp) -$9.6B $675M $2.2B $1.4B $1.2B
Operating Expenses $2.6B $2.4B $2.6B $2.8B $3.1B
Operating Income -$3B $1.8B $14.5B $10.8B $4.5B
 
Net Interest Expenses $1B $1.1B $840M $473M $624M
EBT. Incl. Unusual Items -$13.7B $1.5B $15.9B $11.7B $5.1B
Earnings of Discontinued Ops. $881M $8.4B -- -- --
Income Tax Expense -$2.2B $21M $3.5B $2.4B $779M
Net Income to Company -$10.6B $9.9B $12.4B $9.3B $4.3B
 
Minority Interest in Earnings $440M -$932M -$1.2B -$1.1B -$1.2B
Net Income to Common Excl Extra Items -$10.1B $9B $11.2B $8.2B $3.1B
 
Basic EPS (Cont. Ops) -$15.60 $13.82 $21.65 $19.78 $8.81
Diluted EPS (Cont. Ops) -$15.60 $13.72 $21.50 $19.69 $8.78
Weighted Average Basic Share $1.9B $1.9B $1.6B $1.3B $1B
Weighted Average Diluted Share $1.9B $1.9B $1.6B $1.3B $1B
 
EBITDA -$10.1B $5B $19.2B $15.1B $8.6B
EBIT -$12.7B $2.4B $16.8B $12.7B $6.1B
 
Revenue (Reported) $51.8B $84.6B $137.6B $112.1B $105.7B
Operating Income (Reported) -$3B $1.8B $14.5B $10.8B $4.5B
Operating Income (Adjusted) -$12.7B $2.4B $16.8B $12.7B $6.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.4B $415M $5.3B $8.6B $5.4B
Short Term Investments -- -- $5.5B $3.1B $4.8B
Accounts Receivable, Net $7.2B $5.8B $11B $13.5B $11.6B
Inventory $9.8B $8B $8.1B $8.8B $9.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $893M $2.7B $568M $1.2B $971M
Total Current Assets $30.5B $28.3B $30.5B $35.2B $32.1B
 
Property Plant And Equipment $42.7B $40.6B $38.8B $36.9B $36.3B
Long-Term Investments $6.6B $5.4B $5.4B $6.5B $6.3B
Goodwill $15.7B $8.3B $8.3B $8.2B $8.2B
Other Intangibles -- -- -- -- --
Other Long-Term Assets $3.2B $2.6B $2.4B $3.1B $3B
Total Assets $98.6B $85.2B $85.4B $89.9B $86B
 
Accounts Payable $11.2B $7.8B $13.7B $15.3B $13.8B
Accrued Expenses -- -- -- $315M $316M
Current Portion Of Long-Term Debt $704M $2.9B $571M $1.1B $2B
Current Portion Of Capital Lease Obligations $514M $497M $438M $368M $454M
Other Current Liabilities $2.5B $2.7B $1B $852M $1.3B
Total Current Liabilities $16.9B $15.7B $17.9B $20B $20.2B
 
Long-Term Debt $28B $28.7B $25B $25.6B $25.3B
Capital Leases -- -- -- -- --
Total Liabilities $55.4B $54.9B $51.8B $54.8B $54.6B
 
Common Stock $10M $10M $10M $10M $10M
Other Common Equity Adj -$320M -$512M -$67M $2M -$131M
Common Equity $33.7B $22.2B $26.2B $27.7B $24.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $9.4B $8B $7.4B $7.4B $7B
Total Equity $43.1B $30.2B $33.6B $35.1B $31.4B
 
Total Liabilities and Equity $98.6B $85.2B $85.4B $89.9B $86B
Cash and Short Terms $1.4B $415M $10.8B $11.8B $10.2B
Total Debt $28.7B $31.6B $25.5B $26.7B $27.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $618M $5.9B $7.4B $8.5B $4B
Short Term Investments -- $7.4B $3.8B $4.6B $1.1B
Accounts Receivable, Net $4.9B $9.5B $13.5B $12.5B $10.2B
Inventory $7.4B $9.2B $9.8B $10.1B $9.9B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.2B $2.2B $858M $607M $740M
Total Current Assets $26.2B $34.1B $35.3B $36.3B $25.9B
 
Property Plant And Equipment $41.4B $39.1B $36.6B $36B $35.7B
Long-Term Investments $5.5B $5.4B $6.5B $6.5B $7B
Goodwill $8.3B $8.3B $8.2B $8.2B $8.2B
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.7B $2.5B $3.1B $2.9B $2.9B
Total Assets $84B $89.3B $89.7B $90B $79.8B
 
Accounts Payable $6.7B $12.2B $16.7B $15.8B $12.8B
Accrued Expenses -- -- -- $262M $290M
Current Portion Of Long-Term Debt $2.5B $73M $1.1B $819M $4.2B
Current Portion Of Capital Lease Obligations $531M $444M $355M $453M $485M
Other Current Liabilities $2.6B $1.3B $1.4B $2.1B $1.1B
Total Current Liabilities $14.2B $16.9B $21.3B $21.7B $21.1B
 
Long-Term Debt $29.4B $27.3B $25.6B $26.5B $24.1B
Capital Leases -- -- -- -- --
Total Liabilities $53.5B $53.3B $55.9B $57.2B $54.1B
 
Common Stock $10M $10M $10M $10M $10M
Other Common Equity Adj -$334M -$344M -$179M -$49M -$158M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $8.1B $7.7B $7.5B $6.9B $6.8B
Total Equity $30.5B $36B $33.8B $32.8B $25.7B
 
Total Liabilities and Equity $84B $89.3B $89.7B $90B $79.8B
Cash and Short Terms $618M $13.2B $11.1B $13.1B $5.1B
Total Debt $31.9B $27.3B $26.7B $27.3B $28.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $3.3B -$10B $11B $16.1B $11.2B
Depreciation & Amoritzation $3.2B $3.4B $3.4B $3.2B $3.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.7B $1.5B -$5.3B -$2.3B $2B
Change in Inventories -$362M $1.8B -$33M -$787M -$489M
Cash From Operations $9.4B $2.4B $4.4B $16.4B $14.1B
 
Capital Expenditures $4.8B $2.8B $1.5B $2.4B $1.9B
Cash Acquisitions -$129M -- -- -$413M -$246M
Cash From Investing -$6.3B -$3.3B $14.8B $623M -$3.1B
 
Dividends Paid (Ex Special Dividend) -$1.4B -$1.5B -$1.5B -$1.3B -$1.3B
Special Dividend Paid
Long-Term Debt Issued $14.3B $19.1B $19.6B $3.4B $1.6B
Long-Term Debt Repaid -$13.1B -$16.4B -$25.8B -$2.3B -$1.1B
Repurchase of Common Stock -$2B -- -$4.7B -$11.9B -$11.6B
Other Financing Activities -$1.2B -$1.4B -$2.1B -$1.8B -$1.9B
Cash From Financing -$3.4B -$135M -$14.4B -$13.6B -$14.2B
 
Beginning Cash (CF) $1.5B $1.4B $416M $5.3B $8.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$124M -$979M $4.9B $3.3B -$3.2B
Ending Cash (CF) $1.4B $416M $5.3B $8.6B $5.4B
 
Levered Free Cash Flow $4.6B -$368M $2.9B $13.9B $12.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$609M $1B $5B $3.6B $1B
Depreciation & Amoritzation $830M $836M $794M $845M $846M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$767M $182M $3.9B -$1.8B $2.1B
Change in Inventories $750M -$326M $1.2B -$605M -$107M
Cash From Operations $1.3B -$1.1B $2.5B $5B $1.7B
 
Capital Expenditures $634M $377M $701M $420M $651M
Cash Acquisitions -- -- -- $296M $45M
Cash From Investing -$747M -$2.1B $501M -$435M $2B
 
Dividends Paid (Ex Special Dividend) -$378M -$370M -$285M -$297M -$273M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.5B $200M $994M -- $1M
Long-Term Debt Repaid -$3.8B -$1.2B -$1B -$19M -$773M
Repurchase of Common Stock -- -$928M -$3.9B -$2.8B -$2.7B
Other Financing Activities -$355M -$464M -$512M -$309M -$411M
Cash From Financing -$949M -$2.8B -$4.7B -$3.4B -$4.2B
 
Beginning Cash (CF) $966M $11.8B $9.1B $7.3B $4.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$248M -$6B -$1.7B $1.1B -$439M
Ending Cash (CF) $718M $5.9B $7.4B $8.5B $4B
 
Levered Free Cash Flow $687M -$1.5B $1.8B $4.5B $1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$10.3B $10.5B $13.5B $12.9B $6.2B
Depreciation & Amoritzation $3.4B $3.4B $3.2B $3.3B $3.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $2B -$4.6B -$3.9B $1.6B $2.5B
Change in Inventories $625M -$621M -$622M -$305M $236M
Cash From Operations $3.5B $2B $15.7B $17.4B $7.6B
 
Capital Expenditures $3.7B $1.4B $2.2B $2.1B $2.3B
Cash Acquisitions -- -- -$74M -$339M -$868M
Cash From Investing -$4.5B $12.9B $2.6B -$2.6B $263M
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.5B -$1.3B -$1.3B -$1.2B
Special Dividend Paid
Long-Term Debt Issued $13.7B $24.3B $4.6B $1.6B $1.6B
Long-Term Debt Repaid -$10.7B -$29B -$5.4B -$1.1B -$828M
Repurchase of Common Stock -- -$1.9B -$12.8B -$10.9B -$10.3B
Other Financing Activities -$1.3B -$1.8B -$2B -$2.1B -$1.6B
Cash From Financing $200M -$9.8B -$16.7B -$13.7B -$12.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$808M $5.2B $1.5B $1.1B -$4.5B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$179M $574M $13.5B $15.3B $5.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$10.6B $9.9B $12.4B $9.3B $4.3B
Depreciation & Amoritzation $2.5B $2.6B $2.4B $2.5B $2.5B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $2.3B -$3.8B -$2.4B $1.5B $2.1B
Change in Inventories $1.2B -$1.2B -$1.8B -$1.3B -$588M
Cash From Operations $1.1B $686M $12B $13B $6.5B
 
Capital Expenditures $2.3B $983M $1.7B $1.4B $1.7B
Cash Acquisitions -- -- -$74M -- -$622M
Cash From Investing -$2.8B $13.3B $1.1B -$2.1B $1.2B
 
Dividends Paid (Ex Special Dividend) -$1.1B -$1.1B -$928M -$950M -$862M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $13.2B $18.4B $3.4B $1.6B $1.6B
Long-Term Debt Repaid -$10.1B -$22.7B -$2.3B -$1.1B -$811M
Repurchase of Common Stock -- -$1.9B -$10.1B -$9.1B -$7.8B
Other Financing Activities -$1B -$1.4B -$1.3B -$1.6B -$1.3B
Cash From Financing $922M -$8.7B -$11B -$11B -$9.1B
 
Beginning Cash (CF) $4B $12.9B $21.5B $23.9B $13.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$677M $5.5B $2.1B -$175M -$1.4B
Ending Cash (CF) $3.3B $18.3B $23.6B $23.8B $11.6B
 
Levered Free Cash Flow -$1.2B -$297M $10.3B $11.6B $4.7B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock